Am. J. Respir. Crit. Care Med., Vol 153, No. 3, 03 1996, 1141-1147.
Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis
N Ahmed, R Thorley, D Xia, D Samols and RO Webster
Department of Internal Medicine, St. Louis University School of Medicine, Missouri, USA.
The acute phase protein, C-reactive protein (CRP), can increase more than a
thousandfold during acute inflammatory states, and it is known to modulate
neutrophil-mediated inflammatory responses. We have previously shown that
CRP inhibits chemotaxis of C5a-stimulated neutrophils in vitro and that
rabbits with elevated CRP blood levels exhibit diminished pulmonary
vascular permeability and neutrophil infiltration in a model of alveolitis.
To study the effect of CRP on alveolitis induced by different
chemoattractants, transgenic mice capable of expressing rabbit CRP in a
dietary-inducible fashion were treated with inflammatory doses of the
chemoattractants. Intratracheal installation of FMLP (8 x 10(-10) mol),
LTB4 (2 x 10(-11) mol), or IL-8 (5 x 10(-12) mol) in normal CF1 mice
resulted in significant (p<0.05) influx of neutrophils and protein into
the alveolar space. Transgenic mice with elevated plasma levels of CRP
showed significantly (p<0.05) diminished infiltration of neutrophils
into bronchoalveolar lavage fluid (BALF) and significant reduction in BALF
protein compared with that in normal mice. Rabbit CRP (10 to 500
micrograms/ml) inhibited in vitro neutrophil chemotaxis in a
concentration-dependent fashion when stimulated by the various
chemoattractants examined. These data show that rabbit CRP can modify both
in vivo and in vitro neutrophil responses to several classes of
chemoattractants and that CRP has a significant protective effect in
alveolitis by reducing neutrophil influx and protein leakage into the lung.
This article has been cited by other articles:

|
 |

|
 |
 
W. Rodriguez, C. Mold, M. Kataranovski, J. A. Hutt, L. L. Marnell, J. S. Verbeek, and T. W. Du Clos
C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fc{gamma} Receptors
J. Immunol.,
January 1, 2007;
178(1):
530 - 538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Pitiphat, M. W. Gillman, K. J. Joshipura, P. L. Williams, C. W. Douglass, and J. W. Rich-Edwards
Plasma C-Reactive Protein in Early Pregnancy and Preterm Delivery
Am. J. Epidemiol.,
December 1, 2005;
162(11):
1108 - 1113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Black, I. Kushner, and D. Samols
C-reactive Protein
J. Biol. Chem.,
November 19, 2004;
279(47):
48487 - 48490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Bodman-Smith, R. E. Gregory, P. T. Harrison, and J. G. Raynes
Fc{gamma}RIIa expression with Fc{gamma}RI results in C-reactive protein- and IgG-mediated phagocytosis
J. Leukoc. Biol.,
June 1, 2004;
75(6):
1029 - 1035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mold, W. Rodriguez, B. Rodic-Polic, and T. W. Du Clos
C-Reactive Protein Mediates Protection from Lipopolysaccharide Through Interactions With Fc{gamma}R
J. Immunol.,
December 15, 2002;
169(12):
7019 - 7025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Papafili, M. R. Hill, D. J. Brull, R. J. McAnulty, R. P. Marshall, S. E. Humphries, and G. J. Laurent
Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2002;
22(10):
1631 - 1636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nakamura, L. A. Herzenberg, J. Bai, S. Araya, N. Kondo, Y. Nishinaka, L. A. Herzenberg, and J. Yodoi
Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis
PNAS,
December 6, 2001;
(2001)
191498798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zouki, B. Haas, J. S. D. Chan, L. A. Potempa, and J. G. Filep
Loss of Pentameric Symmetry of C-Reactive Protein Is Associated with Promotion of Neutrophil-Endothelial Cell Adhesion
J. Immunol.,
November 1, 2001;
167(9):
5355 - 5361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Balto, H. Sasaki, and P. Stashenko
Interleukin-6 Deficiency Increases Inflammatory Bone Destruction
Infect. Immun.,
February 1, 2001;
69(2):
744 - 750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Solomkin
Use of knockouts to define sequential steps on a pathway to organ injury: Focus on "Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock"
Am J Physiol Cell Physiol,
February 1, 2001;
280(2):
C237 - C238.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Stein, C. Mold, and T. W. Du Clos
C-Reactive Protein Binding to Murine Leukocytes Requires Fc{gamma} Receptors
J. Immunol.,
February 1, 2000;
164(3):
1514 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Heuertz, S. M. Tricomi, U. R. Ezekiel, and R. O. Webster
C-reactive Protein Inhibits Chemotactic Peptide-induced p38 Mitogen-activated Protein Kinase Activity and Human Neutrophil Movement
J. Biol. Chem.,
June 18, 1999;
274(25):
17968 - 17974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gabay and I. Kushner
Acute-Phase Proteins and Other Systemic Responses to Inflammation
N. Engl. J. Med.,
February 11, 1999;
340(6):
448 - 454.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Jones, D. Novick, S. Horiuchi, N. Yamamoto, A. J. Szalai, and G. M. Fuller
C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
J. Exp. Med.,
February 1, 1999;
189(3):
599 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ayroldi, O. Zollo, L. Cannarile, F. D' Adamio, U. Grohmann, D. V. Delfino, and C. Riccardi
Interleukin-6 (IL-6) Prevents Activation-Induced Cell Death: IL-2-Independent Inhibition of Fas/fasL Expression and Cell Death
Blood,
December 1, 1998;
92(11):
4212 - 4219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhong, Q. Zen, J. Tebo, K. Schlottmann, M. Coggeshall, and R. F. Mortensen
Effect of Human C-Reactive Protein on Chemokine and Chemotactic Factor-Induced Neutrophil Chemotaxis and Signaling
J. Immunol.,
September 1, 1998;
161(5):
2533 - 2540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. MICHEL, A.-M. NAGY, M. SCHROEVEN, J. DUCHATEAU, J. NEVE, P. FONDU, and R. SERGYSELS
Dose-Response Relationship to Inhaled Endotoxin in Normal Subjects
Am. J. Respir. Crit. Care Med.,
October 1, 1997;
156(4):
1157 - 1164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. CASALS, A. VARELA, M. L. F. RUANO, F. VALIÑO, J. PÉREZ-GIL, N. TORRE, E. JORGE, F. TENDILLO, and J. L. CASTILLO-OLIVARES
Increase of C-Reactive Protein and Decrease of Surfactant Protein A in Surfactant after Lung Transplantation
Am. J. Respir. Crit. Care Med.,
January 1, 1997;
157(1):
43 - 49.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Nakamura, L. A. Herzenberg, J. Bai, S. Araya, N. Kondo, Y. Nishinaka, L. A. Herzenberg, and J. Yodoi
Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis
PNAS,
December 18, 2001;
98(26):
15143 - 15148.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|